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The amyloid peptides, Aβ40 and Aβ42, are generated through endoproteolytic cleavage of the amyloid precursor protein. Here we
have developed a model to investigate the interaction of living cells with various forms of aggregated Aβ40/42. After incubation
at endosomal pH 6, we observed a variety of Aβ conformations after 3 (Aβ3), 24 (Aβ24), and 90 hours (Aβ90). Both Aβ4224 and
Aβ4024 were observed to rapidly bind and internalize into diﬀerentiated PC12 cells, leading to accumulation in the lysosome.
In contrast, Aβ40/4290 were both found to only weakly associate with cells, but were observed as the most aggregated using
dynamic light scattering and thioﬂavin-T. Internalization of Aβ40/4224 was inhibited with treatment of monodansylcadaverine,
an endocytosis inhibitor. These studies indicate that the ability of Aβ40/42 to bind and internalize into living cells increases with
degree of aggregation until it reaches a maximum beyond which its ability to interact with cells diminishes drastically.
1.Introduction
Alzheimer’s disease (AD) is a progressive neurological disor-
der resulting from the deposition of Alzheimer β-Amyloid
peptide (Aβ) as senile plaques, the appearance of neu-
roﬁbrillary tangles, and selective neuronal loss. The most
abundant forms of Aβ are 40 and 42 amino acid residues
long and referred to as Aβ40 and Aβ42, respectively
[1].
The endocytic pathway has been implicated in the
extracellular secretion of Aβ40 and Aβ42 [2, 3]. These
peptidesare derived from theendoproteolyticcleavageof the
Amyloid precursor protein (APP) with β-secretase, followed
by γ-secretase. β-secretase cleavage occurs in the acidic late
endosomes [4, 5]. After γ-secretase cleavage, Aβ40 or Aβ42
is free in the endosomal lumen [6]. The endosomal contents
can be either secreted from the cell [7–9]ortransferred tothe
lysosome [10].
T h ee n d o s o m eh a sb e e nf o u n dt ob eq u i t ea c i d i c( p H6 )
with the recycled endosome slightly less acidic (pH 6.5)
[11, 12]. Exposure of Aβ to endosomal pH conditions has
beenfoundtoinducevariousconformationalandoligomeric
states [13–15]. Many oligomeric forms of Aβ have been
proposed and characterized as intermediates in the pathway
to forming the Amyloid ﬁbre. Some of these structures
include trimers, pentamers, high molecular weight Aβ-
derived diﬀusible ligands (ADDLs), protoﬁbrils, and ﬁbrils
[16–21].
Here we present a method for generating a mixed
population of Aβ conformations using model endocytic
conditions.Usingthismethod,wedemonstratethatwhenAβ
is exposed to endosomal conditions for an extended period
of time, the ability of the peptide to bind and internalize into
living rat adrenal pheochromocytoma (PC12) cells increases
with time until it reaches a maximum beyond which its
ability to interact with PC12 cells diminishes drastically.2 International Journal of Alzheimer’s Disease
2.Materialsand Methods
2.1. Peptide Synthesis and Puriﬁcation. Aβ40 and Aβ42 were
synthesized and puriﬁed as described previously [22]. Before
cleavage from the resin, the ﬂuorophore, Nα-(9-Fluorenyl-
methoxycarbonyl)-Nε-tetramethylrhodamine-(5-carbonyl)-
L-lysine (Molecular Probes, Eugene, OR) (abbreviated
TMR), was coupled to the N-terminus via a glycine linker.
The crude peptides were puriﬁed by HPLC using a Superdex
Tricorn 10/300GL Peptide column (Amersham Biosciences,
Piscataway, NJ) with 30mM NH4OH running buﬀer. To
maintain stock peptide solutions free from ﬁbril seeds,
solutions were stored at pH 10 and 4◦C immediately after
chromatographic separation of monomeric peptides. Aβ
preparations were never lyophilized, as this process may
allow for seeds to form. These solution conditions have
been previously shown to maintain the monomeric state
[16, 23, 24]. Peptide purity and identity was conﬁrmed
using both MALDI mass spectrometry and amino acid
analysis. Concentrations of stock peptide solutions were
determined using amino acid analysis and conﬁrmed by
either tyrosine absorbance (275nm, ε = 1390cm−1 M−1)
or TMR absorbance for labelled peptides (550nm,
ε = 92000cm−1 M−1).At least three separate synthesized lots
of Aβ were used in this study and each displayed identical
cell association rates when compared for quality assurance.
Oligomeric samples were prepared by diluting stock Aβ
samples to 30μMw i t h3 0m MN H 4OH and reducing to pH
6 with 0.2M HCl and incubating for zero (Aβ0), 3 (Aβ3), 24
(Aβ24), or 90 hours (Aβ90)i nt h ed a r ka t2 0 ◦C.
2.2. Dynamic Light Scattering (DLS). Hydrodynamic radius
(Rh) measurements were made at 20◦C with a DynaPro DLS
instrument (Protein Solutions Inc., Piscataway, NJ). Peptide
samples (30μM) were reduced to pH 6 using 0.2mM HCl,
centrifugedat12000×gfor3minutesandthenrapidlyadded
to a 1cm path length cuvette and left in the instrument.
DLS data was collected at various time points over 90 hours.
Particle translational diﬀusion coeﬃcients were calculated
from decay curves of autocorrelation of light scattering data
and convertedto hydrodynamic radius (Rh) with the Stokes-
Einstein equation. Histograms of intensity versus Rh were
calculated using Dynamics data analysis software (Protein
Solutions Inc., Piscataway, NJ).
2.3. Filter Assay. Aβ samples (30μM) were either not ﬁltered
or spin-ﬁltered for 30 minutes at 14,000×g using 10,
30, 100kDa (Amicon ultra cellulose KMWO), or 0.1μm
(Amicon PVDF) spin ﬁlters. Absorbance at 550nm was
collectedonaMolecularDevicesSpectraMaxM5 (Molecular
Devices Corp., Sunnyvale, CA) and graphs were created
normalizing the absorbance signal from each ﬁltered sample
to the corresponding unﬁltered sample.
2.4. Thioﬂavin-T Assay. Fluorescence measurements were
obtained using 200μLo f3 0 μMA β samples, within a 96-
well plate, after addition of 5-fold molar excess of thioﬂavin-
T and incubation at room temperature for 30 minutes.
Emission at 485nm was collected using 440nm excitation
on a Molecular Devices SpectraMax M5 (Molecular Devices
Corp., Sunnyvale, CA).
2.5. Cell Culture. PC12 cells were maintained in DMEM/F12
containing 10% fetal bovine serum (HyClone, Logan, UT)
with 100units/mLpenicillinand 100μg/mL ofstreptomycin.
To induce diﬀerentiation of PC12 cells and for cell imaging,
they were plated at 2.2 × 104 cells/cm2 in Lab-tech cham-
bered cover glass chambers and suspended in phenol red
free DMEM/F12 containing N2 supplement and 10ng/mL
NGF. Cells were diﬀerentiated for 72 hours before media
was replaced and peptide treatments (ﬁnal concentration
1.5μM) were performed. Cells were maintained at 37◦Ci n
a humidiﬁed incubator with 5% carbon dioxide.
2.6. Analytical Ultracentrifugation. TMR-labelled Aβ sam-
ples (6μM) were prepared in phenol red free DMEM/F12
media containing N2 supplement and 10ng/mL NGF. Either
fresh media orculturedsupernatants, obtained from cellcul-
ture after 72 hours, were used. To avoid interference from cell
culture components, molecular weights of TMR-labelled Aβ
were obtained by selective monitoring ofTMR absorbance at
550nm. Sedimentationexperiments were performed at20◦C
on a Beckman XLI analytical ultracentrifuge using an AN50-
Ti rotor. Molecular weights were calculated using Beckman
XLI data analysis software in which absorbance versus radial
position data were ﬁtted to the sedimentation equilibrium
equation using nonlinear least-squares ﬁtting.
2.7. Confocal Microscopy. Three-dimensional stacks of ﬂu-
orescence micrographs were taken at 20◦Cw i t hac o n f o c a l
laser-scanning system consisting of an LSM 510 Zeiss
META NLO confocal microscope with a C-APO 40X water
immersion objective (numerical aperture 1.2) and HeNe
laser with a 543nm laser line. The displayed images were
captured using Zeiss LSM Image version 4 and prepared
using ImageJ version 1.37v and represent a single cross-
section through the cells.
2.8. Inhibition of Endocytosis. Diﬀerentiated PC12 cells were
treated with 50μM monodansylcadaverine (MDC) for 20
minutes at 37◦C with 5% carbon dioxide. After inhibitor
treatment, Aβ24 (ﬁnal concentration 1.5μM) was added to
the media containing MDC and imaged after 4 hours at
37◦C. Aβ24 (ﬁnal concentration 1.5μM) was also added to
diﬀerentiated PC12 cells media for 4 hours at either 37◦Co r
4◦C prior to imaging.
2.9. Intracellular Localization. Diﬀerentiated PC12 cells were
ﬁrst treated with Aβ24 (ﬁnal concentration 1.5μM) for 6
hours at 37◦C followed by treatment with 40nM Mito-
Tracker Deep Red and 50nM LysoTracker Green DND-26
for 20 minutes. After treatment, the media was exchanged
with fresh phenol red free DMEM/F12 media containing
N2 supplement and 10ng/mL NGF with 1.5μMD A P If o r
nuclear staining. Cells were imaged using Argon laser with
488nm laser line for LysoTracker, HeNe laser with 633nmInternational Journal of Alzheimer’s Disease 3
laser line for MitoTracker, HeNe Laser with 543nm laser
for TMR-labelled Aβ24, and a tunable Chameleon laser at
730nm for two-photon excitation of DAPI. 2D histograms
and correlation coeﬃcients were determined using Image J
version 1.42q with colocalisation threshold plugin [25].
2.10. Toxicity. Diﬀerentiated PC12 cell media was replaced
with media containing 0.6 to 20μMA β0,A β24,A β90,o r
10μM Melitin as apositive control for48hours. Cell survival
was quantiﬁed using the Sulforhodamine B assay [26],
and absorbance was measured at 560nm using Molecular
Devices SpectraMax M5 (Molecular Devices Corp., Sunny-
vale, CA).LC50 valueswere determined as the concentration
of Aβ required to kill ﬁfty percent of the cells from an
absorbance versus Aβ concentration plot.
3.Results
3.1. Aβ Aggregation Is Mediated through Cell Interaction. To
study the interaction between Aβ a n dl i v ec e l l s ,w es y n t h e -
sized and ﬂuorescently labelled Aβ40/42.The synthesized Aβ
was maintained in solution from puriﬁcation to storage and
wasneverlyophilized,asthesesolutionconditionsareknown
to signiﬁcantly reduce the formation of Aβ aggregation seeds
[16, 23, 24]. We covalently attached tetramethylrhodamine
(TMR) to the N-terminus of Aβ via a ﬂexible glycine
linker to generate TMR-Aβ.T h eN - t e r m i n u so fA β is highly
accessible even in the ﬁbril state [21, 27, 28] and attaching a
ﬂuorescent label to this site has been shown to neither alter
its amyloidogenic properties [16, 29, 30], nor its solubility
behaviour [31, 32].
We have previously shown that treating cultured cells
with 1.5μM monomeric TMR-Aβ42 leads to the formation
of visible aggregates on the surface of PC12 cells within
one hour of treatment [29]. We initiated our current study
by investigating whether Aβ aggregation could occur in cell
culture media alone. Using analytical ultracentrifugation,
we measured the molecular weights of Aβ40 and Aβ42
present in phenol red free cell culture medium, both freshly
prepared and conditioned media taken from diﬀerentiated
PC12 cells 3 days postdiﬀerentiation. Following the addition
of 6μMA β to each medium and subsequent 24-hour
incubation at room temperature, both media preparations
were centrifuged to equilibrium at room temperature in
an analytical ultracentrifuge in order to determine the
molecular weight of Aβ conformations. The molecular
weights of Aβ40 and Aβ42 from both media preparations
were measured to be approximately 4103Da and 4425Da,
respectively. These values both correspond to the expected
monomeric molecular weights of Aβ, falling within the 95%
conﬁdence intervals of 3650–4570Da for Aβ40 and 3650–
4770Da for Aβ42. Thus, the aggregation of Aβ seen by
confocal microscopy apparently occurs only after interaction
with the diﬀerentiated PC12 cells and not with cultured
supernatants. It should be noted that the concentration
previously used to treat cells (1.5μM) and the concentration
used for ultracentrifugation (6μM) are considerably lower
than the reported 20 to 50μMr a n g er e q u i r e df o rin vitro
aggregation [33–35].
3.2. Aβ Oligomerizes at Endosomal pH. We have previously
shown that Aβ40 and Aβ42 aggregate signiﬁcantly at pH 6
[29]. Since Aβ40 and Aβ42 are generated through endopro-
teolytic cleavage [7–9], and the pH of the endosome and
recycled cellular vesicles is equivalent to pH 6 [12], we char-
acterized the Aβ conformations formed under endosome
conditions. Aβ (30μM) was reduced to pH 6, and hydrody-
namic radius calculations were collected after zero (Aβ0), 3
(Aβ3), 24 (Aβ24), and 90 (Aβ90) hours using dynamic light
scattering (Figure 1). The average hydrodynamic radius of
Aβ40wasfoundtoincreasefrom2.0nmattimezero(Aβ400)
to 216nm after 90 hours at pH 6 (Aβ4090). A more striking
increase wasfoundwithAβ42,beginningwith1.7nmat time
zero (Aβ420) to 451nm after 90 hours at pH 6 (Aβ4290).
For each of these samples, the development of increasingly
higher ordered aggregates was observed over time and the
samples that were treated for 90 hours contained particles
over 1000nm in radii.
To further investigate the relative levels of peptide
aggregation at endocytic pH, we ﬁltered the Aβ40 and Aβ42
samples through various molecular weight cutoﬀ (MWCO)
spin ﬁlters (Figure 2). Approximately 67% of Aβ403, 60%
of Aβ4024, and 55% of Aβ4090 were recovered through the
10kDa MWCO spin ﬁlter and approximately 80% were
recovered through the 100kDa MWCO ﬁlter, except for
Aβ4090 with only 60% recovered. In contrast, only 55%
of Aβ423,A β4224,a n dA β4290 were recovered through the
10kDa ﬁlter and approximately 60% were recovered through
the 100nm ﬁlter. These results indicate that the majority of
peptide conformations present under these conditions were
abletopassthrougha10kDamolecularweightﬁlter,butthat
just over 40% could not be recovered through the 100nm
ﬁlter for the Aβ4090,A β423,A β4224,a n dA β4290 samples.
We also used thioﬂavin-T to assess the time-dependence
of the extent of Amyloid ﬁbril formation at endocytic
pH. Thioﬂavin-T is a dye known to shift its ﬂuorescence
from 430nm to 490nm upon binding speciﬁcally to the
cross-β-structure of Amyloids but not to monomeric or
small oligomeric complexes [36, 37]. We observed enhanced
thioﬂavin-T ﬂuorescence at all time points (Figure 3);
however, Thioﬂavin-T bound most strongly to Aβ4090,
Aβ4224,a n dA β4290. The high thioﬂavin-T binding to Aβ90
samples suggests that these late stage Aβ conformations are
the most aggregated.
3.3. Endocytic Aβ Undergoes Rapid Cellular Interaction.
Using confocal microscopy, cell surface association and
internalization of peptides can be monitored. We have
previously shown that monomeric Aβ42 associates with cells
more rapidly than Aβ40, with signiﬁcant staining observable
after six hours of treatment [29]. To determine whether the
aggregation state of Aβ aﬀects cell association, we exposed
each of the Aβ40 and Aβ42 samples to diﬀerentiated PC12
cells and monitored the kinetics of association by confocal
microscopy. Upon treating cells with Aβ4024,t h ec e l ls u r f a c e
association was observed within one hour of treatment
(Figure 4). Moreover, Aβ4024 was observed to signiﬁcantly
internalize into these cells after only 6 hours, whereas sig-
niﬁcant internalization of Aβ400 was only visualized around4 International Journal of Alzheimer’s Disease
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Figure 1: Dynamic light scattering of endocytic Aβ. A time-dependent increase in the average hydrodynamic radius (Rh)w a so b s e r v e dw i t h
incubation of Aβ under endocytic conditions. At each time point, a variety of aggregates are present.International Journal of Alzheimer’s Disease 5
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Figure 2:SeparationofAβ by ultraﬁltration.GraphsshowtheTMRabsorbanceoftheﬁltratesforeach Aβ sampledivided by the absorbance
of the unﬁltered sample at 550nm. Error bars represent the range from two independent experiments.6 International Journal of Alzheimer’s Disease
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Figure 3: Thioﬂavin-T ﬂuorescence of Aβ exposed to endocytic
conditions.Signiﬁcantthioﬂavin-Tﬂuorescence forthe Aβ4090 and
Aβ4290 samples indicates the highest level of aggregation present.
Error bars represent the range of two independent experiments.
Statistical signiﬁcance is indicated (∗) P<. 05.
24 hours (Figure 4). Similarly, Aβ4224 internalized into
diﬀerentiated PC12 cells after only one hour of treatment,
whereas Aβ420 treatment only became observable at 24
hours (Figure 4). Interestingly, when diﬀerentiated PC12
cells were treated with late-stage Aβ4090 or Aβ4290, very few
cells underwent internalization or even exhibited cell surface
interaction with these aggregated peptide forms (Figure 4).
To illustrate the contrast between these treatments, we
collected the three-dimensional image slices through a cell
from the base to the apex for the 6-hour treatment with
Aβ420,A β4224,a n dA β4290 (Figure 5). Aβ420 was only
observed around the periphery of the cell, whereas some
Aβ4224 was located inside the cell. By contrast, Aβ4290
treatment seemed to localize to extracellular regions and did
notproducethe punctatepatternasobservedwith theAβ420
sample.
To quantify the frequency of cells that exhibited peptide
internalization, we randomly selected ﬁve ﬁelds of view
from at least three separate 6-hour treatment experiments
and plotted the percentage of cells having internalized
Aβ (Figure 6). Approximately 25% of cells internalized
Aβ40/423, whereas more than 90% of cells internalized
Aβ40/4224. In contrast, very few cells were found to inter-
nalize Aβ40/4290.S i n c el a t eA β40/4290 was found to have a
large number of aggregates with hydrodynamic radius over
1000nm (Figure 1) and were found to signiﬁcantly bind
thioﬂavin-T (Figure 3), then these aggregates may favour
self-association over cell association.
3.4. Internalization of Aβ Is Mediated through Cellular Import
Mechanisms. Todetermineiftheinternalizationofendocytic
Aβ is mediated through cellular processes, such as receptor-
mediated endocytosis or through direct peptide-mediated
processes like membrane pore formation, we monitored the
eﬀects of temperature and monodansylcadaverine (MDC)
400
4024
4090
420
4224
4290
1 hour 6 hours 24 hours
Aβ
Aβ
Aβ
Aβ
Aβ
Aβ
Figure 4: Confocal Microscopy images showing Aβ time course of
cell entry. Confocal microscopy images of diﬀerentiated PC12 cells
treated with various Aβ samples exposed to endosomal conditions
after 1, 6, and 24 hours. All scale bars are 20μmi nl e n g t h .A β4024
associates rapidly to diﬀerentiated PC12 compared to Aβ400,
whereas Aβ4090 displays weak cell association over its treatment
course. Aβ4224 displays rapid internalization compared to Aβ420.
Aβ4290 displays reduced cell interaction compared to Aβ420 and
Aβ4224.
on internalization. MDC is a known inhibitor of receptor-
mediated clathrin-dependent endocytosis [38, 39]. At phys-
iological temperature (37◦C), after a 4-hour treatment of
cells with Aβ4024 and Aβ4224, internalization was observed
(Figure 7). At 4◦C membrane vesicle formation is inhibited,
preventing endocytosis of extracellular and cell surface
components [40]. When Aβ4024 or Aβ4224 association with
diﬀerentiated PC12 cells was monitored at 4◦C, none of
the cells were found to have internalized these peptidesInternational Journal of Alzheimer’s Disease 7
Cell
apex
Cell
base
420 4224 4290 Aβ Aβ Aβ
(a) (b) (c)
Figure 5: Image planes though a single cell for each Aβ42 treatment. Confocal microscopy images from diﬀerentiated PC12 cell base to cell
apex for Aβ420,A β4224,a n dA β4290, with the TMR signal only (a) and TMR cell merged image (c). All scale bars are 10μmi nl e n g t h .
(Figure 7). Similarly, when diﬀerentiated PC12 cells were
treatedwith MDC,neitherAβ4024 nor Aβ4224 were observed
within the cells. These observations indicated that Aβ24
was internalized through a cell-directed import mechanism,
rather than an independent penetration route through the
cell membrane.
3.5. Internalized Aβ Is Targeted to the Lysosome. The location
of deposited intracellular Aβ40/4224 was examined using
intracellular organelle markers in diﬀerentiated PC12 cells.
Cells treated with Aβ4024 and Aβ4224 for 6 hours were
visualized usingLysoTrakerGreenDND-26forthelysosome,
MitoTracker Deep Red for the mitochondria, and DAPI for8 International Journal of Alzheimer’s Disease
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Figure 6: Percentage of PC12 cells with internalized Aβ.A β4024
and Aβ4224 were more signiﬁcantly internalized into diﬀerentiated
PC12 cells than the other forms of Aβ.A β4090 and Aβ4290 display a
striking drop in the amount of internalization.Error bars represent
the standard deviation from at least three individual experiments
with n>200 cells per condition. Statistical signiﬁcance is indicated
(∗) P<. 005.
4024
4224
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Figure 7: Inhibition of Aβ internalization. Confocal microscopy
images of diﬀerentiated PC12 cells treated with Aβ40/4224 for 4
hours. All scale bars are 20 μm in length. Internalization was only
observed at 37◦C. Membrane integrity was maintained throughout
all treatments, indicating that internalizationis mediated through a
cellular process such as clathrin-dependent endocytosis.
nucleus staining (Figure 8). The staining pattern of each
cellular organelle marker in the same image plane as the
Aβ4024 and Aβ4224 treatment was determined (Figure 8)
and quantiﬁed (Figure 9). Only the signal from the lysosome
marker costained with both internalized Aβ4024 and Aβ4224.
The red signal from the peptides costained well with green
signal from the lysosomes, resulting in the yellow signal in
the merged image. When quantiﬁed, 71% of the lysosome
signal intensity colocalised with the Aβ40 channel and
80% with the Aβ42 channel (Figure 9). Whereas only
9% of the mitrochondria signal intensity colocalised with
Aβ40 channel and less than 1% with the Aβ42 channel
(Figure 9). These ﬁndings suggest that the internalized
vesicles containing Aβ40/4224 are directed to the lysosome.
The intensity of bothAβ4024 andAβ4224 ﬂuorescencesignals
was found to increase in the lysosomes over time, which may
reﬂect the accumulation of Aβ40/4224 in the lysosome.
To determine the relative toxicity of these Aβ conforma-
tions,acytotoxicityassaywasperformedwherediﬀerentiated
PC12 cells were treated with various peptide concentrations
for 48 hours (Figure 10). We calculated the lethal concen-
tration at which 50% of cells were killed (LC50), for each of
theAβconformations.WefoundthatAβ4024 wasmoderately
more toxic than Aβ400, with a lower LC50 value (Figure 10).
Surprisingly, Aβ4090 was also found to have a lower LC50
value compared to Aβ400.A β4224 was also found to be
moderately more toxic than Aβ420,w h e r e a sA β4290 had a
much higher LC50 value compared to Aβ420 (Figure 10).
4.Discussion
We have developed a method to produce a collection of Aβ
conformations that diﬀer in their extent of aggregation and
investigated the interaction between these states of Aβ40 and
Aβ42 and diﬀerentiated PC12 cells. Others have described
the methods to isolate individual soluble oligomeric forms
of Aβ, using various chemical reagents and protocols [41–
44]. In addition, puriﬁed oligomeric Aβ molecules from
cell culture [45, 46] or transgenic mice [47] have also been
monitored. These puriﬁed sources of oligomeric Aβ oﬀer
greatpotentialinunderstandingtheprogressionofAβaggre-
gation; however, they cannot be directly visualized over the
time course of their eﬀects on cells during maturation from
earlier to later conformations. Since it is well established
that Aβ monomers can oligomerize under the physiological
pH of the endosome [13–15], and Aβ is formed through
endoproteolytic cleavage, we have utilized this condition to
determine which conformations are present and how these
mixed conformations interact with diﬀerentiated PC12 cells.
It is known that the extent of oligomerization/ﬁbrillation
is very dependent on experimental conditions. Necula et
al. [48] have indicated that Aβ can be induced to form
ﬁbrils via dilution from 100mM NaOH to neutral pH
in the presence of 10mM HEPES/100mM NaCl buﬀer,
while dilution into phosphate buﬀered saline results in
oligomer formation. In our experiments, the peptide was
diluted from 30mM ammonium hydroxide (pH 10) to
pH 6 with ﬁnal condition of 1mM ammonium chloride as
the only additional chemical. We do note that the normal
human physiological concentration of ammonium chloride
in blood and cerebrospinal ﬂuid is approximately 20 to
50μM[ 49, 50], and that hyperammonemia has been linking
to Alzheimer type II astrocytosis [51, 52].
When extracellular monomeric Aβ associates to the sur-
face of cells, we speculate there are three possible outcomes:
(1) it can act as a stable template to allow further Aβ
aggregation; (2) the peptide can penetrate through the cell
membrane depositing in the cytoplasm; or (3) the peptide
may be internalized into the cell within endocytic vesicles,
which would result in a reduction in the surrounding pH.
In the third case, the endocytic vesicles containing Aβ canInternational Journal of Alzheimer’s Disease 9
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theoreticallyberecycledbacktothecellsurface ordirected to
the lysosome where a further reduction in pH would occur.
We have previously visualized oligomeric Aβ on the surface
of neuronal cell lines [29], and here sought to determine
ﬁrst whether this aggregation occurred prior to cell surface
deposition in the cell culture mediaor are aggregation
and cell surface binding concomitant and linked processes.
Using ultracentrifugation analysis of Aβ preparations either
in freshly prepared cell culture media or in conditioned
media removed from cultured cells after 3 days, we did
not observe any conformation larger than the monomer.
These results indicate that components in our cell media
or secreted factors from cultured cells are not responsible
for the observed Aβ aggregation present on the surface of
neuronal cells. After adding monomeric Aβ to cells, we
noted a maturation time for the visual appearance of Aβ on10 International Journal of Alzheimer’s Disease
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the cell surface and in the cell interior (Figure 4;[ 29]). We
postulate that the peptides on the cell surface might undergo
a series of pHreductions through endocyticrecycling,before
becoming visible punctae on and inside the cell. Since pH 6
is approximately endocytic pH, we characterized the kinetic
eﬀects of this condition on peptide conformations. Exposing
Aβ40 for up to 24 hours at pH 6, we observed an increase
in the average hydrodynamic radius from 2.0nm (Aβ400)t o
183nm (Aβ4024)( F i g u r e1). In addition, approximately 60%
of these peptides were recovered through a 10kDa MWCO
ﬁlter and 80% were recovered through a 100kDa MWCO
ﬁlter (Figure 2), and only minor thioﬂavin-T binding was
found (Figure 3). Following exposure of up to 24 hours at
pH 6, Aβ4 2h a da ni n c r e a s ei nt h ea v e r a g eh y d r o d y n a m i c
radius from 1.7nm (Aβ420) to 246nm (Aβ4224)( F i g u r e1),
approximately 55% were recovered through 10kDa MWCO
ﬁlter and only 60% were recovered through 100nm ﬁlter
(Figure 2) and more signiﬁcant thioﬂavin-T binding was
measured (Figure 3). Both Aβ40 and Aβ42 treated for
90 hours at pH 6 were observed to have large average
hydrodynamic radius particles, with 40% of these samples
being withheld by a 100nm ﬁlter and both displayed
signiﬁcant thioﬂavin-T staining. Also, these early-and late-
stage Aβ samples were observed to have an ensemble of Aβ
conformations (Figure 1).
The interactions of these early-and late-stage Aβ con-
formations were monitored with diﬀerentiated PC12 cells.
Whereas late stage Aβ4090 and Aβ4290 exhibited very few
interactions with cells (Figures 4, 5) and internalized at a
very low frequency (Figure 6), early stage Aβ4024 and Aβ4224
interacted with cells rapidly (Figure 4) and internalized
into the majority of the cells present (Figure 6). Interest-
ingly, Aβ4024 showed a more rapid cellular association and
internalization compared to Aβ400 (Figure 4). Similarly,
Aβ4224 was found to internalize more rapidly than Aβ420,
indicating that a speciﬁc conformation may play a role in
cell binding and internalization. Furthermore, our model
of endocytic Aβ toxicity (Figure 10) is in agreement with
previous ﬁndings utilizing chemically-produced oligomers
of Aβ which showed that Aβ ﬁbrils were less toxic than
soluble oligomers [41, 53]. Our results with Aβ90 are also in
agreement with studies that have indicated that regions with
large Amyloid plaques do not correlate directly with regions
of signiﬁcant neuronal loss [54, 55].
Many studies have reported that certain oligopeptides
are freely imported into cells. For example, the peptide
sequences corresponding to Tat (48–60), penetratin, and
oligoarginine are known to internalize into live cells. Cellular
import of Tat (48–60) and penetratin was shown to be
temperature dependent,indicating the possible role ofendo-
cytosis for internalization [56, 57]. In contrast, oligoarginine
containing C-terminal tryptophan was shown to follow a
nonendocytic pathway, independent of energy requirements
and temperature [57]. Another type of internalization
process has been studied in the bacterium Clostridium
septicum, whose alpha toxin contains functional domains
responsible for oligomerization and cellular pore formation.
Using speciﬁc domains that bind cell surface receptors,
alpha toxin monomers oligomerize to form pores in human
cells and thus impose direct entry [58]. By exposing Aβ
to endosomal conditions, we were able to observe internal-
ization of Aβ40/4224, which was inhibited at 4◦Co rw i t h
the endocytosis inhibitor MDC (Figure 7). Throughout the
course of our confocal experiments, we did not observe any
disruption of the cell membrane, which would have been
expected if membrane channels or pores were being formed
by Aβ. Thus, the structural conformation of Aβ that was
observed to internalize into cells seems to follow a cell-
mediated import mechanism.
Our results with the various Aβ conformations correlate
directly with previous reports that indicate the deposition
of Aβ in the lysosome [15, 59, 60] and with the previous
study that internalized Aβ can persist undegraded for days
[61].Fromourﬁndings takentogetherwith previousstudies,
we present the following model for the interaction of Aβ
with neuronal cells (Figure 11). As monomeric Aβ binds
the cell surface, this event could lead to a conformational
change allowing for the further catalytic aggregation of Aβ.
R e c e n t l y ,i th a sb e e ns h o w nt h a to l i g o m e r i cA β binds to
GM1 ganglioside and alters physical properties ofthe plasmaInternational Journal of Alzheimer’s Disease 11
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Figure 11: A plausible mechanism of Aβ neurotoxicity.
membrane which stimulates the amyloidogenic processing
pathway of APP [62, 63]. Aβ that is bound to the cell
surface may become internalized and recycled, allowing
for acidiﬁcation and further aggregation, which in turn
may stimulate additional Aβ generation [62]. Once the
surface Aβ reach some speciﬁc structural form, they may
be internalized and directed to the lysosome for potential
degradation. However, the reduced pH of the lysosome may
instead cause further aggregation and persistence of Aβ,
resulting in lysosomal overload and cell death. The recently
reported high turnover rate of monomeric Aβ [64, 65]a n d
the formation of large aggregate pools of Aβ may indicate
that the human body uses these mechanisms to sequester
and remove the toxic Aβ oligomers from neuronal cells.
With age, the turnover rate for monomeric Aβ may slow
down, which could then result in the initiation of our
proposed mechanism and may contribute to the late onset
of Alzheimer’s disease. It is also possible that endocytosis
of Aβ and lysosomal targeting are mechanisms by which
the cell clears Aβ aggregates from the cell surface. Also,
certain large aggregates of Aβ may just be too large for the
cell to internalize, and they may represent the precursor for
extracellular Amyloid formation.
5.Conclusion
Our study shows that using a simple method to generate
various Aβ conformations, the rates of cellular interaction
and targeting can be followed with live cell cultures. Using
this model, we found that early endocytic conformations,
rather than highly aggregated late forms, serve as the major
contributors to rapid cell internalization. The mechanism
of internalization likely involves a cell surface receptor-
mediated process instead of peptide-mediated direct entry,
resulting in accumulation in the lysosome. This method
allowsforconformation-speciﬁc therapeuticsandconditions
to be screened with live cells, circumventing the need to
purify speciﬁc Aβ conformations.
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